4 of the Highest-Growth Stocks in Biotech Today
Investing in the biotech industry can be a risky business. In most instances, the deck is stacked against a company succeeding. The vast majority of preclinical studies will fail to reach human trials, and there's no guarantee that a compound in clinical trials will reach pharmacy shelves. Not surprisingly, about 9 in 10 biotech stocks are currently losing money, and some simply may not survive.
However, if you do manage to pick a drug developer that brings exciting, game-changing therapies to market, your investment could increase many times over. A good example is Pharmacyclics, which is now under the ownership of AbbVie. Pharmacyclics wound up developing blood cancer drug Imbruvica, ultimately leading to a 45,700% price appreciation from its Great Recession lows to its buyout price just a few years later. Every investors' goal is to snag a rocket like Pharmacyclics, and the best way to do that is to look for high-growth companies in the biotech industry.
Based on Wall Street's consensus estimates, the following four biotech stocks offer some of the highest growth today.
Source: Fool.com
Merck & Co. Inc. Stock
With 32 Buy predictions and 1 Sell predictions Merck & Co. Inc. is one of the favorites of our community.
With a target price of 125 € there is a slightly positive potential of 16.6% for Merck & Co. Inc. compared to the current price of 107.2 €.